The National Academy of Medicine report released Thursday, Opportunities to Improve Opioid Use Disorder and Infectious Disease Services: Integrating Responses to a Dual Epidemic,
The first U.S. patient to be diagnosed with the novel coronavirus first reported in Wuhan, China highlights needs for expanded readiness to detect, prevent and respond to this virus and those to come, at home and abroad.
The IDSA Board of Directors has added ten members to those receiving the Fellow of IDSA Designation. FIDSA is the ID profession’s highest honor given to those who demonstrate excellence and leadership in the field. See the full list of 2019 FIDSA designees.
The bankruptcy filing announced today by antibiotic maker Melinta once again highlights the daunting challenges facing research and development of new infection-fighting drugs.
The spending bill passed today is a welcome step forward. Allocations in the bill will strengthen public health and research efforts during the year ahead and will provide critical support for important goals.
H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act passed by the House of Representatives today introduces critically needed and significant steps to reduce costs and improve access to life-saving therapies for conditions including HIV and hepatitis C.
Today’s subcommittee hearing on U.S. preparedness and responses for the 2019-2020 flu season offers an important opportunity to examine and act on gaps and challenges exacerbating the public health threats of seasonal influenza outbreaks.
HCVguidelines.org was recently revised to reflect important developments in the identification and management of chronic hepatitis C.
This World AIDS Day marks a promising and unprecedented point in a quest begun nearly four decades ago to end the global public health threat of HIV through science and solidarity.
The Antibiotic Resistance Threats Report released by the CDC today shows that while recent federal investments to combat antibiotic resistance have had meaningful impacts, the continued spread of infections that are not effectively treated by existing medicines pose deadly threats to patients and public health.
Among patients with severe sepsis, early consultation with an ID specialist was associated with 40 percent lower mortality, a new study in Open Forum Infectious Diseases finds.
Clinical Infectious Diseases articles examine child deaths at U.S. immigrant detention centers.